Anti-CD131/CSF2RB/IL3RB/IL5RB antibody

单克隆

小鼠

小鼠IgG1

Mouse monoclonal to CD131/CSF2RB/IL3RB/IL5RB

FCM

FCM

Human CD131 / CSF2RB / IL3RB / IL5RB

CD131, IL3RB, IL5RB, SMDP5, CDw131, Bc, Il3r, AIC2B, Il3rb, Il5rb, CDw131, Il3rb1, Csf2rb1, Csfgmrb, AI848964, AI848964, AIC2B, Bc, CD131, CDw131, CDw131, CSF2RB, Csf2rb1, Csfgmrb, GM-CSF/IL-3/IL-5 receptor common beta-chain, GM-CSF/IL-3/IL-5 receptor common beta-chain, Il3r, IL3RB, Il3rb, Il3rb1, Il5rb, IL5RB, MGC130522

This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD131 / CSF2RB / IL3RB / IL5RB (rh CD131 / CSF2RB / IL3RB / IL5RB; NP_000386.1; Met1-Trp443) and conjugated with APC under optimum conditions, the unreacted APC was removed.

Aqueous solution containing 0.5% BSA and 0.09% sodium azide

This antibody is stable for 12 months from date of receipt when stored at 2℃-8℃. Protected from prolonged exposure to light. Do not freeze !
Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.

Colony stimulating factor 2 receptor, beta, low-affinity (CSF2RB) also known as CD131 antigen (CD131), cytokine receptor common subunit beta, GM-CSF/IL-3/IL-5 receptor common beta-chain, interleukin 3 receptor/granulocyte-macrophage colony stimulating factor 3 receptor, beta (IL3RB), is the common beta chain of the high affinity receptor for IL-3, IL-5 and CSF. Defects in this protein have been reported to be associated with protein alveolar proteinosis (PAP). CD131 belongs to the type I cytokine receptor family. The cluster of differentiation (cluster of designation) (often abbreviated as CD) is a protocol used for the identification and investigation of cell surface molecules present on white blood cells initially but found in almost any kind of cell of the body, providing targets for immunophenotyping of cells. Defects in CD131/CSF2RB are the cause of pulmonary surfactant metabolism dysfunction type 5 (SMDP5). SMDP5 is a rare lung disorder due to impaired surfactant homeostasis. It is characterized by alveolar filling with floccular material that stains positive using the periodic acid-Schiff method and is derived from surfactant phospholipids and protein components. Excessive lipoproteins accumulation in the alveoli results in severe respiratory distress.

• <